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What is already known about this topic? 
• Solar UVB radiation is the major source of vitamin D for humans and it is strongly associated 
with vitamin D status.  
• UVB radiation at wavelengths that can induce vitamin D synthesis can be approximated by 
total UV or UVB radiation, sunshine hours or latitude; typically averaged over a large 
geographical region and long time period, yielding unreliable approximations. 
 
What does this study add? 
• Freely available data on measured ambient UVB exposure at wavelengths required for 
vitamin D synthesis (vitD-UVB) and adjusted for cloud cover and ozone layer is a powerful 
yet entirely underutilized epidemiological tool to study the relationships between UVB, 
vitamin D and health outcomes. 
• There was a significant geographical variation in vitD-UVB, even within a small geographic 
area at a northern latitude.  
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• Measured ambient vitD-UVB dose at place of residence is a good predictor of vitamin D 
status in healthy adult population.  
 
Abstract 
 
Background. Solar ultraviolet radiation is the major source of vitamin D for humans.  
Objectives. We use high-resolution geo-temporal measurements to describe ambient UVB radiation 
at wavelengths that induce vitamin D synthesis (vitD-UVB) in Scotland, and examine the relationship 
of this exposure to 25-hydroxyvitamin D (25OHD) measured in plasma of 1,964 healthy adults.  
Methods. We estimated the average vitD-UVB dose for each day of the year, and for each postcode 
area in Scotland using the Tropospheric Emission Monitoring Internet Service database (TEMIS, 
2005-2010). Cumulative and weighted vitD-UVB (CW-vitD-UVB) exposure at the place of residence, 
prior to the date of blood sampling was calculated for each participant. Plasma 25OHD was assayed 
in 1,964 healthy participants. 
Results. Statistically significant seasonal (highest in June) and geographic (highest in south) variation 
in vitD-UVB was observed, even within a small geographic area in a northern latitude. Ambient 
vitD-UVB exposure at the place of residence was significantly associated with plasma 25OHD (p<10E-
10). An average increase of 1 ng/mL in 25OHD was observed for every 1000 kJ/m2 higher CW-vitD-
UVB dose or for every 2.5 µg of daily supplement taken. Adequate 25OHD concentration (>16 
ng/mL) was observed in majority of individuals when CW-vitD-UVB dose was above 6000 kJ/m2, a 
level of ambient radiation achieved only in summer months in Scotland. When predicting vitamin D 
deficiency, dramatic improvement in AUC was observed after CW-vitD-UVB dose was added to the 
model in addition to a range of other covariates (from 0.55 to 0.70). 
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Conclusions. We conclude that ambient vitD-UVB is a measurable exposure that can be useful 
predictor of vitamin D status. Geo-temporally mapped measurements of vitD-UVB can be used as a 
proxy for vitamin D status or as an important covariate in epidemiological research, particularly if 
25OHD is not available.  
 
Introduction 
Seasonality of vitamin D status follows seasonality of UVB radiation and attests to the key role of 
UVB as a source of vitamin D 1. Because skin synthesis is directly related to the UVB exposure, there 
is a strong a priori expectation that ambient UVB dose predicts vitamin D status. However, there is a 
paucity of studies that exploit UVB measurement; this could be in part due to difficulties in obtaining 
accurate individual estimates, as ambient UVB dose does not directly map to latitude, sunshine, 
season or weather. Previous attempts have estimated UVB dose using crude proxies such as 
sunshine hours or latitude 2–4, typically averaged over a large geographical region and longer time 
period, yielding unreliable approximations. Apart from few rare exceptions 5, more accurate 
estimates of UVB relevant for vitamin D production have not been examined or utilised in 
epidemiological studies to date.  
The amount of vitamin D synthetized in skin depends on two principal determinants: (i) available 
UVB at wavelengths relevant for vitamin D production and (ii) personal factors (Figure 1) 6. While the 
ambient dose is easily measureable, personal characteristics and behaviours are not, because they 
are highly variable and difficult to capture (e.g. clothing, time spent outside, or tan) 7. Therefore, an 
accurate estimate of ambient UVB dose at wavelengths relevant for vitamin D production is a critical 
measurable predictor of vitamin D status 2.  
Once vitamin D is synthesised (or ingested), it undergoes hydroxylation in the liver to form 25-
hydroxyvitamin D (25OHD). The concentration of 25OHD in the circulation is currently considered to 
be the best biomarker of vitamin D status 8. However, it is not always feasible to measure circulating 
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25OHD due to assay costs and difficulty (practical or ethical) of obtaining blood samples, particularly 
if assessment at multiple time-points is desired 9.  
In this paper, we set out to describe ambient exposure to UVB radiation at wavelengths that can 
induce vitamin D synthesis (vitD-UVB) in Scotland, and to examine the relationship between ambient 
vitD-UVB at the place of residence and vitamin D status. We also discuss the relevance and 
application of this novel approach for future studies. 
Methods 
 
Study Population 
The study population consists of 1964 individuals (43% female) recruited as control subjects 
between February 2003 and March 2004 for a case-control study aimed at investigating factors 
associated with colorectal cancer (SOCCS) in Scotland. The study is described in detail elsewhere 10,11. 
All participants were white Caucasians of Scottish ancestry (genetic markers were used to verify 
this). Participants completed a detailed socio-demographic and lifestyle questionnaire, a semi-
quantitative food frequency and a supplements questionnaire. We administered the Scottish 
Collaborative Group Food Frequency Questionnaire (SCG-FFQ, Version 6.41), which has been 
validated in Scotland. Nutrient content was estimated for each food item using national nutritional 
database. Nutrients intakes were calculated from the consumption frequencies of specified portion 
size for each food item from the FFQ and were standardized for total energy intake. 
Residential postcode was mapped within 30’ of geographical latitude and longitude to UVB radiation 
database grid (55 km south-to-north and 33 km east-to-west at the latitudes of Scotland). The final 
sample size (n=1964) followed exclusion of participants (n=284) with missing data on any of: 
residential location; level of physical activity; BMI; plasma 25OHD level; or extreme outliers of 
plasma vitamin D (>100 ng/ml). Approval for the study was obtained from the Multicentre Research 
Ethics Committee for Scotland and Local Research Ethics committees and all participants gave 
written informed consent.  
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Plasma vitamin D measurement and deficiency categories  
Blood samples were taken throughout the year (Supplementary Table 1). All plasma samples were 
batched and assayed at the same laboratory. Total 25-OHD (25-OHD2 and 25-OHD3) was measured 
by liquid chromatography-tandem mass spectrometry which is considered the gold-standard 
method 12. The lower limit of detection for this method is 4 ng/mL; values below the limit were 
replaced with a value randomly sampled from the 0-4 ng/mL range from a tail of normal distribution, 
to improve normality. To characterise the degree of deficiency, categorical 25OHD cut-off points 
were set to 10, 16 and 20 ng/mL in accordance with Ross et al. (2011)13, although risk categories cut-
offs are still under debate 14,15. 
 
Genetic Score 
We have extracted the genotypes for three SNPs (rs12785878, rs10741657 and rs2282679) that 
have been associated with 25OHD concentration in genome-wide association study16. Genetic score 
has been calculated as the number of risk alleles for rs12785878 and rs2282679, variants that have 
been associated with circulating 25OHD in this population. Genotyping protocol has been described 
in detail elsewhere17. Approximately one third of the cohort had no risk alleles (n=527), 63% 
(n=1021) had 1 or 2 risk alleles, while 4% had 3 or 4 risk alleles (n=65). 
 
UVB Data Resource  
We extracted ambient UVB dose relevant for vitamin D production at residential locations for every 
participant using the Tropospheric Emission Monitoring Internet Service (TEMIS) database 
(www.temis.nl/uvradiation). Daily estimates are based on satellite UV measurements from sunrise 
to sunset, with a time step of 10 minutes. The readings are adjusted for the terrain elevation, the 
total ozone column and cloud cover (Figure 1) 18.  
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The exposure dose is the energy associated with the radiation divided by the surface area of the 
receptor, expressed in kilo-Joules per square meter (kJ/m2). A biological function is applied to the 
intensity of UV radiation, to isolate the narrow band of wavelengths relevant for vitamin D 
production. Synthesis occurs within the UVB wavelengths, but while action spectrum is between 260 
and 315 nm, the peak conversion occurs at a very narrow range: between 295 and 297 nm 19. The 
final estimate is the daily dose of UV radiation at the earth’s surface that can induce vitamin D 
synthesis if absorbed by the human skin (vitD-UVB).  
Because observed vitD-UVB measurement was not available prior to 2005 when this cohort was 
being recruited, average daily vitD-UVB dose was calculated for each day of the year (DD/MM) using 
data recorded between 2005 and 2010 (DD/MM/YYYY). 
 
Seasonal and Geographic Analysis of VitD-UVB in Scotland 
Total monthly vitD-UVB exposure averaged over five (or six) years (July 2005 to October 2010) was 
calculated and is reported for eight exemplar areas selected to represent diverse geographical 
locations while accounting for population density: Glasgow, Edinburgh, Oban, Aberdeen, Inverness, 
Stornoway, Kirkwall and Lerwick. Multivariate linear regression was carried out to examine the 
association between total monthly vitD-UVB dose and month, location and year.  
Mean monthly vitD-UVB dose was calculated for 79 grid cells that cover the entire land area of 
Scotland. The map of Scotland was created using Postal Boundaries Open 2012, a spatial dataset 
detailing the extent of the 9,232 geographic postal sectors (e.g. HP21 8) covering Great Britain (last 
modified: October 2012). Postal sectors are grouped together to form 2,736 Postal Districts (e.g. 
HP21) which in turn group together to form 120 Postal Areas (e.g. HP). The data is released under 
the same terms as the OS OpenData license 20.  
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Individual cumulative and weighted vitD-UVB (CW-vitD-UVB) exposure dose 
Mean daily vitD-UVB dose for each day of the year (DD/MM) for each region was calculated using 
data from 2005 to 2010 (DD/MM/YYYY) for that region. A cumulative and weighted vitD-UVB dose 
prior to date of blood sampling was calculated for each individual based on the average estimated 
dose. “Cumulative” means that daily vitD-UVB doses from a number of preceding days are added up 
to contribute to the final exposure estimate, but using a method where daily contributions to the 
cumulative exposure estimate are weighted so that vitD-UVB exposures immediately prior to blood 
sampling contribute more than exposures from a more distant past (Supplementary Figure 1). This 
weighting is akin to the “half-life” of vitD-UVB effect and reflects the half-life of vitamin D in the 
body (whole-body vitamin D: 2 months; 25OHD in the circulation: 15 days 21). Our analysis suggests a 
35-day half-life of vitD-UVB effect and 135-day period are optimal parameters (see Supplementary 
Methods). The model presumes that the amount of vitD-UVB currently contributing to plasma 
concentration is negligible 135 days prior to sampling. The estimates are unique for every individual, 
because they are determined by the place of residence and date of blood sampling. For example, if 
blood sample was taken on 27/01, data on daily vitD-UVB doses between 14/09 and 26/01 will be 
extracted, weighted and added up. This is illustrated in Supplementary Figure 1 and Equation 1, 
where x = days ago (starting day before and up to 135 days prior to sampling), y = rate of 
disappearance of effect of UVB in days (half-life set at 35 days), and e^(-ln2*(x/y) is the weighing 
formula applied.  
 
(Equation 1)  
Statistical Analysis  
We tested whether cumulative and weighted vitD-UVB (CW-vitD-UVB) dose was associated with 
25OHD, in regression analysis after adjustment for a range of factors that have been shown to affect 
25OHD concentration (age, sex, body mass index, number of risk alleles, socio-economic status, level 
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of physical activity, dietary vitamin D and vitamin D supplements use). The proportion of variance 
explained by each predictor in this population was estimated, to assess relative contributions to 
25OHD levels in this population. A drawback with population variance measures is that the major 
determinants of population variation may not be the main causes of the condition; therefore it is not 
possible to rank the absolute importance of factors according to their contribution to population 
variance.  
The ability of the 25OHD-UVB proxy to predict plasma vitamin D status in three categories 
(<10ng/ml, <16 ng/ml and <20ng/ml) was tested using random forests prediction (RF). While logistic 
regression models predict the category of an observation based on linear combinations of the 
predictor variables, RF uses classification trees.  A classification tree is fitted for each predictor 
variable, with each variable given a cut-off value corresponding to being vitamin D deficient or not. 
RF prediction fits many classification trees to randomly selected subsets of the data, and then 
combines the predictions from all the trees. The success of the prediction for each observation is 
calculated by combining the results of all the classification trees. The main advantage of RF 
compared to logistic regression is it has very high classification accuracy. Repeated classification 
trees are made from separate bootstrap samples of the training data using the Classification and 
Regression Tree (CART) algorithm. Each tree provides a prediction rate for the number of individuals 
correctly classified below or above the cut-off point. Receiver operator curves (ROC curves) were 
constructed to measure the performance of the test and the area under the curve (AUC) was 
reported. The AUC is the percentage of randomly drawn pairs correctly classified. The training 
dataset, on which the predictions were made, consisted of 982 observations, while the validation 
set, which was used for the ROC curves, had remaining 982 measurements. The analysis was carried 
out in the randomForest package in R 22.  
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Results 
 
Ambient VITD-UVB Exposure: regional and seasonal differences 
Substantial regional differences in UVB radiation dose at wavelengths that can induce vitamin D 
synthesis (VitD-UVB) were observed across Scotland and throughout the year. As expected, vitD-UVB 
dose was inversely related to latitude (Figure 2 and Supplementary Table 2). Location within 
Scotland was significantly associated with VitD-UVB radiation, despite the restricted geographic area 
(54.8-62.3° North and 0.25-8.25° West): for example, Edinburgh (55.9° N) received on average 560 
kJ/m2 vitD-UVB more per month than Lerwick (60.2° N) (Supplementary Table 3).  
VitD-UVB dose had a marked seasonal pattern and comparisons by month of the year revealed very 
large differences (Figure 2 and Supplementary Table 2). Both the highest daily and highest 
cumulative monthly VitD-UVB dose were consistently observed in the month of June and the lowest 
in December (2005-2010): monthly vitD-UVB dose in June was approximately 100 times higher than 
in December. In the multivariate regression model, month remained very strongly associated with 
vitD-UVB dose (p<0.001); for example, vitD-UVB in June was on average 5,621 kJ/m2 higher than in 
January.  
 
Association between VITD-UVB exposure and 25OHD in the SOCCS cohort 
In total 1964 healthy participants (843 female) from Scotland aged between 22 and 82 were 
included in this study. The mean 25OHD was 14.14 ng/mL (SD=9.01). Peak concentrations and 
highest proportion of sufficient samples were observed in August (Supplementary Figure 2A-B). In 
total 510 (45% female) participants reported taking supplements, median dose was 5 µg (SD=3.58). 
For other characteristics of this population see Zgaga et al. 15. 
Mean cumulative and weighted vitD-UVB in this cohort was 3894 kJ/m2 (SD=2745; median 3923 
kJ/m2, IQR: 1217-6510). While ambient daily vitD-UVB radiation dose in Scotland is the highest in 
June, CW-vitD-UVB estimate peaks approximately 1-2 months later (Supplementary Figure 2C-D).  
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We observed a very strong association between plasma 25OHD and the cumulative and weighted 
vitD-UVB exposure estimate, in both the unadjusted and adjusted analysis (p<2x10-16, Table 1 and 
Figure 3). CW-vitD-UVB was associated with an average 25OHD concentration increase of 1 ng/mL 
for every 1000 kJ/m2. After adjustment for age, sex, BMI, socioeconomic class, level of physical 
activity, dietary vitamin D and supplements, the proportion of variance explained (PVE) by the CW-
vitD-UVB exposure estimate was 10.94% in the whole cohort, 13.22% among those who do not take 
vitamin D supplements (n=1,455) and 6.09% among those who do take supplements (n=510). 
Differences in 25OHD concentration according to the level of CW-vitD-UVB exposure were more 
pronounced in supplement non-takers (Supplementary Figure 3A-B). Adequate vitamin D status 
(>16 ng/mL, “sufficient or at low risk of deficiency”) was mostly achieved when CW-vitD-UVB was 
above 6000 kJ/m2 (a dose is typically achieved only in summer months in Scotland) in individuals 
below the age of 50 (Supplementary Figure 3C-D). 
Not surprisingly, after stratification by the season of blood sample, in winter months we did not 
observe any association between UVB estimate and 25OHD. In contrast, the association between 
supplement use and plasma 25OHD was the strongest in winter and spring, when skin synthesis is 
low (p=2.35x10-6 and p=6.49x10-6) and explained 5.63% and 4.0% of the variance in 25OHD (only 
0.59% in the summer). Vitamin D supplementation was associated with an average of 0.4 ng/mL 
greater plasma level for every 1 µg of daily supplement. For every additional risk allele 25OHD 
concentration was on average 1 ng/mL lower (p=0.0004). Notably, vitamin D from dietary sources 
excluding supplements, explained only a small proportion of the variance in plasma 25OHD (0.4%).  
Stratification by age confirmed particularly strong relationship between 25OHD and CW-vitD-UVB in 
those under 50: average 25OHD levels were over 15 ng/mL higher in those with highest levels of 
CW-vitD-UVB exposure compared to those who had CW-vitD-UVB below 1000 kJ/m2. UVB exposure 
estimate explained 19% of variance, while supplement use was not associated with 25OHD 
concentration in this group.  
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Predictive ability of cumulative weighted vitD-UVB estimate for vitamin D deficiency 
Cumulative weighted vitD-UVB exposure estimate was found to make a large contribution to 
predicting vitamin D deficiency (Figure 4). The final model (Model 6) included cumulative weighted 
vitD-UVB exposure estimate and: age, sex, BMI, number of risk alleles, socioeconomic class, level of 
physical activity, dietary vitamin D and supplements use. When evaluated in the validation dataset, 
improved AUC was observed for models that included cumulative weighted vitD-UVB exposure 
estimate, particularly for predicting severe deficiency: for cut-off at 10 ng/mL AUC was 0.70 
(improved from 0.55), for deficiency cut-off at 16 ng/mL AUC was 0.69 (improved from 0.60), and for 
20ng/ml AUC was 0.70 (improved from 0.64). The variables with the largest determined importance 
in the final model are vitD-UVB, supplement use and age (Supplementary Figure 4).  
 
Discussion 
We set out to examine the relationship between the dose of UVB relevant for vitamin D production 
at the place of residence and vitamin D status, and determine if this exposure can be used to predict 
vitamin D status. The UVB radiation relevant for vitamin D production is determined daily for Europe 
and is readily available through the Tropospheric Emission Monitoring Internet Service (TEMIS). In 
addition to much greater geo-temporal resolution, these data offer a further improvement over UVB 
estimates used previously: measured daily dose of solar radiation is considered rather than an 
approximation of it; wavelengths relevant for vitamin D production only are extracted, and 
adjustments are made for terrain elevation, local ozone column and cloudiness 18. Earlier estimates 
have been based on surveys of hours of sunshine 7, full UV spectrum expressed as the erythemal 
dose, measured at a single geographic location 2 or a small number of locations 3, or fixed ozone and 
cloud cover 23.  
As a result of the gradual accumulation of vitamin D during summer months and gradual diminution 
of reserves in the months when solar radiation is low, a “lag of seasons” is observed for 25OHD 
concentration. We found that in Scotland peak vitD-UVB occurs in June, while peak 25OHD occurs 1-
A
cc
ep
te
d 
A
rt
ic
le
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2 months later, as has been observed previously 24. We developed a simple method to calculate 
exposure for each individual: a cumulative and weighted ambient UVB exposure that accounts for 
gradual accumulation and diminution and allows estimation of vitamin D status at a particular point 
in time (here date of blood sample).  
We showed a very strong association between measured 25OHD concentration and cumulative and 
weighted ambient UVB exposure at the place of residence, at wavelengths relevant for vitamin D 
production (vitD-UVB). Although predictive ability of the final model with all relevant covariates was 
not complete, a dramatic improvement in the AUC curve was observed after addition of vitD-UVB 
estimate. This suggests that ambient UVB is major determinant of vitamin D deficiency, even in a 
high-latitude region 25,26. The association is particularly strong in summer and autumn (when UVB 
dose is high) and in individuals under 50, which is consistent with previous research 27 . 
We observed significant regional variations in vitD-UVB exposure within Scotland, controlling for 
temporal and seasonal differences. This highlights that variation exists even in a relatively small 
northerly country without great differences in latitude as a result of local conditions, accentuating 
that precise local measurements which we consider should be favoured over crude macro-estimates 
of UVB exposures. The regional variation in vitD-UVB within the small area has not been previously 
reported. During the summer months there was a high daily variability in vitD-UVB between the 
different postcodes within Scotland, which decreased dramatically as level of UVB fell during the rest 
of the year. This suggests that geographical differences are likely to be even greater in lower latitude 
regions where UVB exposures are overall higher. 
Many studies previously have shown a positive relationship between supplementation and 
circulating vitamin D levels 28. In this study, the association with 25OHD levels was the strongest in 
winter and spring (when UVB dose is very low or following months of diminution), and this finding 
emphasises the role of vitamin D supplementation in winter months. Interestingly, supplementation 
was not associated with vitamin D status in younger participants (<50 y). Dietary intake had minimal 
effect on in vitamin D status, with was expected because it is now widely accepted that food sources 
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of vitamin D are scarce 15,29. The relationship between genetic factors and 25OHD was similar to 
what was reported previously16. 
It is important to emphasise that the proportion of variance explained is not a measure of the 
effect30. PVE is strongly determined by the variation of the exposure in the population: in a 
population living an outdoor-oriented lifestyle and residing in a region where sunshine UVB is 
abundant, majority of variation in 25OHD may be due to genetic factors or skin tone, and not UVB 
(because it is uniformly abundant everywhere). However, UVB radiation would still be the primary 
cause of vitamin D production. We found that UVB explained 11% of variance in 25OHD in this 
population overall, but it explained almost no variation in 25OHD in winter. It is reasonable to 
assume that proportion of variance explained by UVB could be greater in regions where the annual 
oscillations in UVB radiation dose are greater.  
 
Applications and Uses of Method 
With the exception of few studies, accurate individual measures of ambient UVB have been largely 
underexploited in research. We suggest that the routinely collected data on UVB exposure can be 
used to approximate vitamin D status when 25OHD levels are not measured or blood sample is not 
available. Existing past UVB dose recordings allow investigation of the relationship between UVB 
estimate as a proxy of vitamin D and outcomes retrospectively in existing cohorts at virtually no cost. 
Alternatively, UVB exposure data can be used to adjust 25OHD measurement for date of sampling, 
or it can be used in conjunction with 25OHD to predict average yearly 25OHD of each individual 31. 
Furthermore, randomized control trials (RCT) into the effects of vitamin D intakes on health 
outcomes can suffer from confounding by high exposure to naturally occurring VitD-UVB. Skin 
synthetized vitamin D can dominate 25OHD concentration and mask any impact of vitamin D 
supplementation on circulating level and/or study outcomes. We suggest that ambient UVB should 
be added as a covariate in the analysis, as ignoring “personal” vitamin D supplements use among 
participants in vitamin D RCTs has been shown to affect the findings previously 32. Finally, UVB 
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exposure can be used as an instrument for Instrumental Variable Analysis and provide some insights 
into causality 2,33.  
Strengths. The principal major strength of this study is the use of an all-encompassing UVB estimate 
from daily satellite measurements, restricted to wavelengths relevant for vitamin D production, and 
adjusted for regional terrain and atmospheric conditions (cloudiness and ozone)34,35. To our 
knowledge, this study used the highest geographical resolution of the exposure to date with respect 
to the place of residence, and was the first study that correlated accurate individualised ambient 
vitD-UVB exposure and 25OHD levels. Study comprised large number of participants that are 
homogeneous regarding skin type (all participants were white Scottish.  
Limitations. Information on personal characteristics and behaviours were largely unknown, for 
example “sun holidays” or sunscreen use, or time spent outside. However, sunlight exposure 
questionnaires were shown to provide poor estimates of vitamin D status 7,9. The additional benefit 
of adjusting the vitD-UVB estimate for these factors is currently unknown. However, this means that 
the vitD-UVB exposure used here is not confounded by personal behaviours. Because of the narrow 
range of both UVB dose (high latitude) and supplements (conservative intake recommendations 36,37) 
at low doses, we were not able to examine these exposures at higher levels. As observed vitD-UVB 
data is only available since July 2005, daily UVB dose had to be estimated for each day of the year 
(DD/MM) from available data. As a consequence, the random measurement error in our UVB 
estimate could bias our results towards the null (ie. attenuate effect size)38 and more accurate 
measurements are likely to yield even stronger associations and better predictors in the future.  
 
Conclusions. There is a significant seasonal and geographical variation in ambient vitD-UVB 
exposures in Scotland, despite this being a relatively small country without large differences in 
latitude. The cumulative and weighted ambient vitD-UVB exposure estimate was a good predictor of 
vitamin D status. The TEMIS database of ambient VitD-UVB exposures can be useful for 
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epidemiological research, aimed at examining relationships between UVB/vitamin D and health 
outcomes.  
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Table 1. Multivariate Linear regression models describing the personal characteristics relevant for the synthesis of 
vitamin D. Plasma 25OHD levels were associated with cumulative weighted vitD-UVB exposure estimate, supplement 
use and dietary Vitamin D, adjusting for age, sex, BMI, socioeconomic class and level of physical activity. Percentage of 
variance explained was calculated by partitioning the sum of squares between predictors for covariates of interest.  
 
  
  
  Cumulative 
Weighted vitD-
UVB  Supplements Dietary Vitamin D Genetic Risk Score 
Model 
n 
Plasma 
25OHD 
ng/ml, 
Median 
(IQR) 
P
V
E 
Beta 
Coeff
icient 
(in 
000s) 
P 
Val
ue 
PV
E 
Beta 
Coeff
icient 
P 
Valu
e PVE 
Beta 
Coeff
icient 
P 
Val
ue 
PV
E 
Beta 
Coeff
icient 
P 
Valu
e 
All cohort 1963 
12.9 (7.8 
– 19.0) 
11.
16 1 
< 
2E-
16 
1.42 0.368 3.19E
-09 0.27 0.153 
0.01
1 0.65 
-
0.864 
3.90E
-04 
Suppleme
nt taking               
Yes 510 
15.0 
(10.4 – 
21) 
6.8
9 1 
4.06
E-
08 
0.32 0.142 0.198 0.033 -0.041 
0.74
6 2.25 
-
1.561 0.001 
No 1543 
12.0 (7.0 
– 18.0) 
13.
18 1 
< 
2E-
16 
n/a n/a n/a 0.49 0.252 0.001 0.33 
-
0.619 
2.81E
-02 
BMI <25 726 
13.0 (7.0 
– 19.7) 
9.0
4 1 
1.29
E-
12 
2.1 0.45 1.46E
-04 0.27 0.165 
0.16
9 1.56 -1.37 0.001 
BMI ≥25 1237 
12.5 (8.0 
– 18.2) 
12.
56 1 
< 
2E-
16 
1.19 0.336 1.12E
-04 0.23 0.139 
0.12
8 0.28 
-
0.561 0.06 
Age               
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<50 246 
14.8 (7.3 
– 21.3) 
22.
01 2 
3.18
E-
12 
0.02
6 0.078 0.79 0.051 -0.11 0.69 
0.00
7 0.1 0.89 
50-59 579 
13.5 (8.1 
– 20.9) 
8.8
2 1 
1.96
E-
11 
1.89 0.461 0.001 0.33 0.195 0.184 1.55 
-
1.511 0.004 
60-69 579 
13.0 (8.0 
– 18.0) 
9.5
1 1 
5.09
E-
12 
1.31 0.309 0.005 0.48 0.161 0.15 1.04 -0.915 0.018 
>70 559 
11.4 (7.0 
– 17.0) 
11.
29 1 
1.57
E-
14 
2.05 0.37 8.41E
-04 0.66 0.259 
0.04
4 0.46 
-
0.675 0.118 
Season               
Winter* 387 
10.0 (5.0 
– 14.0) 
0.0
02 -1 
0.84
4 4.69 0.618 
1.39E
-04 0.03 0.07 
0.69
8 0.83 
-
0.931 0.094 
Spring 369 
10.0 (6.0 
– 16.0) 
4.2
4 2 
3.25
E-
04 
4.19 0.519 2.98E
-04 0.11 
-
0.097 
0.48
7 0.04 0.177 0.725 
Summer 621 
16.0 
(11.1 – 
23.0) 
4.3
8 1 
2.84
E-
06 
0.47 0.25 0.0885 0.86 0.292 
0.04
1 0.41 -0.69 0.131 
Autumn 586 
13.0 (8.0 
– 19.0) 
3.1
3 1 
7.32
E-
04 
0.99 0.28 0.012 0.48 0.187 0.126 1.98 
-
1.479 
7.29E
-03 
Male 1121 
13 (8.0 – 
19) 
12.
39 1 
< 
2E -
16 
1.02 0.295 0.0007 0.072 79 0.38 0.42 0.692 0.032 
Female 842 
12.9 (7.0 
– 19) 
9.7
7 1 
< 
2E -
16 
1.95 0.472 4.58E
-05 0.95 0.306 
0.01
2 0.92 -1.03 0.006 
Physical 
Activity               
1 1055 
12.0 (7.0 
– 17.05) 
10.
3 1 
< 
2E-
16 
1 0.001 1.41E
-03 0.11 0.093 
0.34
4 0.13 
-
0.395 0.246 
2 533 
13.3 (8.0 
– 19.3) 
12.
4 1 
2.66
E-
08 
2.1 0.457 8.07E
-04 1.34 0.409 
9.24
E-
03 
2.4 -1.685 0.004 
3 253 
15.0 (9.7 
– 21.0) 
10.
24 1 
6.14
E-
03 
1.98 0.434 0.034 0.69 0.204 0.318 0.55 
-
0.895 0.262 
4 122 
15.0 (9.1 
– 21.1) 
16.
45 1 
2.70
E-
04 
0.84 0.249 0.279 0.29 -0.121 
0.58
4 0.28 
-
0.562 0.556 
Genetic 
risk score               
0 527 
13.7 (7.7 
-21.0) 12 1 
< 
2E-
16 
4.38 0.687 1.13E
-07 0.36 0.189 
0.21
1 n/a n/a n/a 
1 or 2 1021 
12.7 (8 
.0- 18.3) 
10.
3 1 
< 
2E-
16 
0.54 0.208 0.011 0.29 0.145 0.089 n/a n/a n/a 
3 or 4 65 10.1 (70. 
- 17.2) 
16.
9 1 
0.01
4 0.01 
-
0.076 0.912 0.007 
-
0.025 
0.93
8 n/a n/a n/a 
 
Footnote:  
* Seasons defined as December to February, March to May, June to August and September to November respectively.  
PVE: proportion of variance explained. Proportion of variance explained by the exposure will depend on: (a) strength of the association 
between exposure and the outcome, but also on the (b) variation of the exposure in the population. Therefore, while causal relationships 
remain unchanged, varying exposure level in a population will strongly impact on the proportion of variance explained by that exposure. 
Therefore, it does not make sense to evaluate the contribution of exposures in absolute terms, but it can be a useful descriptive measure 
for relative comparisons in a population. IQR: interquartile range; PA: Level of physical activity (hours of running, cycling, and other sports 
activities; four categories).  
Genetic risk score was calculated as the number of risk alleles (associated with decreasing 25OHD) for two SNPs: rs12785878 and 
rs2282679  
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Figure 2.  Average monthly ambient dose of UVB radiation that can induce Vitamin D synthesis 
(vitD-UVB; kJ/m2) in Scotland for March, June, September and December.  
 
 
Footnote: Colour gradient indicates regional variation in vitD-UVB dose in a given month using 
average monthly vitD-UVB (July 2005 - October 2010). Note a very large differences in the scale 
between four selected months. 
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* Footnote: 
SES = Socioeconomic Class. 667 (33.96%) participants were severely deficient (25OHD below 10 ng/mL), 583 (29.68%) were at high and 311 (15.84%) at low 
risk of deficiency (10-16 ng/mL and 16-20 ng/mL, respectively) and only 403 (20.52%) were vitamin D sufficient (25OHD >20 ng/mL). 
 
n=1613 AUC 
Model Predictors <10ng/ml <16ng/ml <20ng/ml 
1 
Sex, age, BMI, 
Ses 0.496 0.547 0.579 
2 
Model 1 + 
number of risk 
alleles 0.514 0.558 0.573 
3 
Model 2 + 
dietary vitamin 
D 0.524 0.581 0.594 
4 
Model 3 + 
Physical 
activity 0.528 0.59 0.619 
5 
Model 4 + 
Supplementary 
vitamin d 0.551 0.598 0.636 
6 
Model 5 + 
vitD-UV 0.703 0.694 0.697 
